메뉴 건너뛰기




Volumn 57, Issue 1-3, 2013, Pages 115-124

B cell regulation of anti-tumor immune response

Author keywords

Anti tumor response; B cell suppression; B regulatory cell; T regulatory cell

Indexed keywords

CD20 ANTIGEN; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OX40 LIGAND;

EID: 84891489921     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-013-8472-1     Document Type: Article
Times cited : (46)

References (21)
  • 1
    • 0037388954 scopus 로고    scopus 로고
    • Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo
    • 12668647 10.1084/jem.20021290 1:CAS:528:DC%2BD3sXivFaisb4%3D
    • Linton PJ, et al. Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med. 2003;197(7):875-83.
    • (2003) J Exp Med , vol.197 , Issue.7 , pp. 875-883
    • Linton, P.J.1
  • 2
    • 0031863680 scopus 로고    scopus 로고
    • B cells inhibit induction of T cell-dependent tumor immunity
    • 9585241 10.1038/nm0598-627 1:CAS:528:DyaK1cXjtFKgtrY%3D
    • Qin Z, et al. B cells inhibit induction of T cell-dependent tumor immunity. Nat Med. 1998;4(5):627-30.
    • (1998) Nat Med , vol.4 , Issue.5 , pp. 627-630
    • Qin, Z.1
  • 3
    • 27144471717 scopus 로고    scopus 로고
    • Increased rejection of primary tumors in mice lacking B cells: Inhibition of anti-tumor CTL and TH1 cytokine responses by B cells
    • 10.1002/ijc.21177 1:CAS:528:DC%2BD2MXhtFKjs7rE
    • Shah S, et al. Increased rejection of primary tumors in mice lacking B cells: inhibition of anti-tumor CTL and TH1 cytokine responses by B cells. Int J Cancer J Int du Cancer. 2005;117(4):574-86.
    • (2005) Int J Cancer J Int du Cancer , vol.117 , Issue.4 , pp. 574-586
    • Shah, S.1
  • 4
    • 79955539126 scopus 로고    scopus 로고
    • The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model
    • Tadmor T, et al the absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model. Cancer Immunol Immunother. 2011;60(5):609-19.
    • (2011) Cancer Immunol Immunother , vol.60 , Issue.5 , pp. 609-619
    • Tadmor, T.1
  • 5
    • 84872489363 scopus 로고    scopus 로고
    • B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion
    • 22772949 10.1007/s00262-012-1313-6 1:CAS:528:DC%2BC3sXosl2rsQ%3D%3D
    • Zhang Y, et al. B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion. Cancer Immunol Immunother. 2013;62(1):87-99.
    • (2013) Cancer Immunol Immunother , vol.62 , Issue.1 , pp. 87-99
    • Zhang, Y.1
  • 6
    • 77954505663 scopus 로고    scopus 로고
    • Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity
    • Watanabe R, et al. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol. 2010;184(9):4801-9.
    • (2010) J Immunol , vol.184 , Issue.9 , pp. 4801-4809
    • Watanabe, R.1
  • 7
    • 43049156086 scopus 로고    scopus 로고
    • A regulatory B cell subset with a unique CD1dhiCD5 + phenotype controls T cell-dependent inflammatory responses
    • 18482568 10.1016/j.immuni.2008.03.017 1:CAS:528:DC%2BD1cXmtlagt78%3D
    • Yanaba K, et al. A regulatory B cell subset with a unique CD1dhiCD5 + phenotype controls T cell-dependent inflammatory responses. Immunity. 2008;28(5):639-50.
    • (2008) Immunity , vol.28 , Issue.5 , pp. 639-650
    • Yanaba, K.1
  • 8
    • 0029045255 scopus 로고
    • Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells
    • 7749983 10.1016/1074-7613(95)90031-4 1:CAS:528:DyaK2MXlvVWrsLY%3D
    • Stuber E, et al. Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity. 1995;2(5):507-21.
    • (1995) Immunity , vol.2 , Issue.5 , pp. 507-521
    • Stuber, E.1
  • 9
    • 0035337241 scopus 로고    scopus 로고
    • CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice
    • 11359859 1:CAS:528:DC%2BD3MXjvFaqs7c%3D
    • Malmstrom V, et al. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J Immunol. 2001;166(11):6972-81.
    • (2001) J Immunol , vol.166 , Issue.11 , pp. 6972-6981
    • Malmstrom, V.1
  • 10
    • 26444547693 scopus 로고    scopus 로고
    • Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNA
    • 15908450 10.1093/intimm/dxh255 1:CAS:528:DC%2BD2MXlslyjsb4%3D
    • Mestas J, et al. Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNA. Int Immunol. 2005;17(6):737-47.
    • (2005) Int Immunol , vol.17 , Issue.6 , pp. 737-747
    • Mestas, J.1
  • 11
    • 0036857838 scopus 로고    scopus 로고
    • Consequences of OX40-OX40 ligand interactions in langerhans cell function: Enhanced contact hypersensitivity responses in OX40L-transgenic mice
    • 12555678 10.1002/1521-4141(200211)32:11<3326: AID-IMMU3326>3.0. CO;2-9 1:CAS:528:DC%2BD38XovF2qsLs%3D
    • Sato T, et al. Consequences of OX40-OX40 ligand interactions in langerhans cell function: enhanced contact hypersensitivity responses in OX40L-transgenic mice. Eur J Immunol. 2002;32(11):3326-35.
    • (2002) Eur J Immunol , vol.32 , Issue.11 , pp. 3326-3335
    • Sato, T.1
  • 12
    • 33645074150 scopus 로고    scopus 로고
    • Activated T cells express the OX40 ligand: Requirements for induction and costimulatory function
    • 16423055 10.1111/j.1365-2567.2005.02279.x 1:CAS:528:DC%2BD28Xit1Siurc%3D
    • Mendel I, Shevach EM. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function. Immunology. 2006;117(2):196-204.
    • (2006) Immunology , vol.117 , Issue.2 , pp. 196-204
    • Mendel, I.1    Shevach, E.M.2
  • 13
    • 0034668824 scopus 로고    scopus 로고
    • A critical role for B cells in the development of memory CD4 cells
    • 11067910 1:CAS:528:DC%2BD3cXot1Grs70%3D
    • Linton PJ, Harbertson J, Bradley LM. A critical role for B cells in the development of memory CD4 cells. J Immunol. 2000;165(10):5558-65.
    • (2000) J Immunol , vol.165 , Issue.10 , pp. 5558-5565
    • Linton, P.J.1    Harbertson, J.2    Bradley, L.M.3
  • 14
    • 33644862359 scopus 로고    scopus 로고
    • Signals from OX40 regulate nuclear factor of activated T cells c1 and T cell helper 2 lineage commitment
    • 16501042 10.1073/pnas.0600205103 1:CAS:528:DC%2BD28XivFWis78%3D
    • So T, et al. Signals from OX40 regulate nuclear factor of activated T cells c1 and T cell helper 2 lineage commitment. Proc Natl Acad Sci U S A. 2006;103(10):3740-5.
    • (2006) Proc Natl Acad Sci U S A , vol.103 , Issue.10 , pp. 3740-3745
    • So, T.1
  • 15
    • 0141539378 scopus 로고    scopus 로고
    • OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses
    • 12938213 10.1002/eji.200324031 1:CAS:528:DC%2BD3sXnsFKltL0%3D
    • Ishii N, et al. OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses. Eur J Immunol. 2003;33(9):2372-81.
    • (2003) Eur J Immunol , vol.33 , Issue.9 , pp. 2372-2381
    • Ishii, N.1
  • 16
    • 0032213337 scopus 로고    scopus 로고
    • OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors
    • 9787171 1:CAS:528:DyaK1cXntFCqtrY%3D
    • Ohshima Y, et al. OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. Blood. 1998;92(9):3338-45.
    • (1998) Blood , vol.92 , Issue.9 , pp. 3338-3345
    • Ohshima, Y.1
  • 17
    • 0031872028 scopus 로고    scopus 로고
    • CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1
    • 9670042 10.1084/jem.188.2.297 1:CAS:528:DyaK1cXkvVaqt7k%3D
    • Flynn S, et al. CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J Exp Med. 1998;188(2):297-304.
    • (1998) J Exp Med , vol.188 , Issue.2 , pp. 297-304
    • Flynn, S.1
  • 18
    • 33644652161 scopus 로고    scopus 로고
    • NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma
    • 16613351
    • Dong HP, et al. NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma. Am J Clin Pathol. 2006;125(3):451-8.
    • (2006) Am J Clin Pathol , vol.125 , Issue.3 , pp. 451-458
    • Dong, H.P.1
  • 19
    • 84881458660 scopus 로고    scopus 로고
    • Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma
    • 23851682 10.4049/jimmunol.1301317 1:CAS:528:DC%2BC3sXht1WiurzN
    • Ganesan AP, et al. Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma. J Immunol. 2013;191(4):2009-17.
    • (2013) J Immunol , vol.191 , Issue.4 , pp. 2009-2017
    • Ganesan, A.P.1
  • 20
    • 42649094145 scopus 로고    scopus 로고
    • Surmounting tumor-induced immune suppression by frequent vaccination or immunization in the absence of B cells
    • 18391756 10.1097/CJI.0b013e31816bc74d
    • Oizumi S, et al. Surmounting tumor-induced immune suppression by frequent vaccination or immunization in the absence of B cells. J Immunother. 2008;31(4):394-401.
    • (2008) J Immunother , vol.31 , Issue.4 , pp. 394-401
    • Oizumi, S.1
  • 21
    • 84876008718 scopus 로고    scopus 로고
    • Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L
    • 23365136 10.1158/0008-5472.CAN-12-4184 1:CAS:528:DC%2BC3sXltVOksL4%3D
    • Bodogai M, et al. Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L. Cancer Res. 2013;73(7):2127-38.
    • (2013) Cancer Res , vol.73 , Issue.7 , pp. 2127-2138
    • Bodogai, M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.